Longitudinal assessment of bone mineral density in prostate cancer patients: comparing metastatic and non-metastatic regions.

Int J Clin Oncol · 2025 · PMC11946959 · PMID 39918769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As previously reported [ 21 ], BMD is higher at sites with bone metastases in prostate cancer, and our study showed a trend towards higher bone density at these sites.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.